SAN FRANCISCO, Nov. 11, 2026 /PRNewswire/ — Skribe Medical, a U.S. medical technology company developing wearable cardiac monitoring for cancer care, today announced progress in its clinical development program following selection of its Aurora System for the U.S. Food and Drug…